Talicia

AssetAlso called omeprazole, amoxicillin, and rifabutin

Stage
Approved
Modality
Small molecule
Target
Not known
1
Indication
0
Trials
1
Developer

Approved by the FDA on Nov 1, 2019 (NDA213004). FDA

Indications

1
  • Helicobacter pylori infection

    Approved, FDA

In the full profile

  • Owner and partners1
  • Competitors5

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets